Ignite Creation Date:
2024-05-06 @ 5:01 PM
Last Modification Date:
2024-10-26 @ 2:20 PM
Study NCT ID:
NCT05161195
Status:
RECRUITING
Last Update Posted:
2024-06-13
First Post:
2021-12-03
Brief Title:
Roll-over Study to Allow Continued Access to Ribociclib
Sponsor:
Novartis Pharmaceuticals
Organization:
Novartis